To further screen the crucial genes affecting the prognosis and IDH status of GBM in the prognostic risk model, in-depth analysis was performed, and the results of survival analysis and ROC analysis also confirmed that abnormal RARRES2 overexpression was associated with the poor prognosis of GBM patients. This evidence concerns the gene RARRES2 and glioblastoma.